Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMAT - ultrafast tomography for coronary artery disease -- Ignore unavailable to you. Want to Upgrade?

To: Bruce Rozenblit who wrote (2955)	3/11/1999 3:37:00 PM
From: John R Resseger	Respond to of 3725

Bruce The questions were rhetorical. Answers 1 No 2 No 3 Should. Doctors are generally consevitive and Insurance companies Blue Cross etc also. Most new medical tech stuff is a dificult sell. Imatron has place units in most of the leading edge cardiac hospitial in the country. They have to be care how the product is marketed. The medical world is a closed shop. They rub people the wrong way they will be cooked. Once the scan gains exceptance it will sell its self. John